Literature DB >> 1908096

Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.

M Higuchi1, H H Kazazian, L Kasch, T C Warren, M J McGinniss, J A Phillips, C Kasper, R Janco, S E Antonarakis.   

Abstract

Hemophilia A is an X chromosome-linked disorder resulting from deficiency of factor VIII, an important protein in blood coagulation. A large number of disease-producing mutations have been reported in the factor VIII gene. However, a comprehensive analysis of the mutations has been difficult because of the large gene size, its many scattered exons, and the high frequency of de novo mutations. Recently, we have shown that nearly all mutations resulting in mild-to-moderate hemophilia A can be detected by PCR and denaturing gradient gel electrophoresis (DGGE). In this study, we attempted to discover the mutations causing severe hemophilia A by analyzing 47 unselected patients, 30 of whom had severe hemophilia and 17 of whom had mild-to-moderate disease. Using DGGE as a screening method, we analyzed 99% of the coding region, 94% of the splice junctions, the promoter region, and the polyadenylylation site of the gene. We found the mutation in 16 of 17 (94%) patients with mild-to-moderate disease but in only 16 of 30 (53%) patients with severe hemophilia A. Since DGGE after computer analysis appears to detect all mutations in a given fragment, the lower-than-expected yield of mutations in patients with severe disease is likely not due to failure of the detection method; it is probably due to the presence of mutations in DNA sequences outside the regions studied. Such sequences may include locus-controlling regions, other sequences within introns or outside the gene that are important for its expression, or another gene involved in factor VIII expression that is very closely linked to the factor VIII gene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908096      PMCID: PMC52304          DOI: 10.1073/pnas.88.16.7405

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

Authors:  V C Sheffield; D R Cox; L S Lerman; R M Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis.

Authors:  L S Lerman; K Silverstein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 4.  The molecular basis of hemophilia A in man.

Authors:  S E Antonarakis; H H Kazazian
Journal:  Trends Genet       Date:  1988-08       Impact factor: 11.639

5.  Moderately severe hemophilia A resulting from Glu----Gly substitution in exon 7 of the factor VIII gene.

Authors:  H Youssoufian; C Wong; S Aronis; H Platokoukis; H H Kazazian; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

6.  An arginine to cysteine amino acid substitution at a critical thrombin cleavage site in a dysfunctional factor VIII molecule.

Authors:  M Shima; J Ware; A Yoshioka; H Fukui; C A Fulcher
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

7.  Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA.

Authors:  C Wong; C E Dowling; R K Saiki; R G Higuchi; H A Erlich; H H Kazazian
Journal:  Nature       Date:  1987 Nov 26-Dec 2       Impact factor: 49.962

8.  Mutations of factor VIII cleavage sites in hemophilia A.

Authors:  J Gitschier; S Kogan; B Levinson; E G Tuddenham
Journal:  Blood       Date:  1988-09       Impact factor: 22.113

9.  Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372----histidine).

Authors:  M Arai; H Inaba; M Higuchi; S E Antonarakis; H H Kazazian; M Fujimaki; L W Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Gamma delta beta-thalassemia due to a de novo mutation deleting the 5' beta-globin gene activation-region hypersensitive sites.

Authors:  M C Driscoll; C S Dobkin; B P Alter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

View more
  32 in total

1.  Mutation analysis of factor VIII in Korean patients with severe hemophilia A.

Authors:  Chur-Woo You; Hee-Sook Son; Hee Jin Kim; Eui-Jeon Woo; Soon-Ae Kim; Haing-Woon Baik
Journal:  Int J Hematol       Date:  2010-06-10       Impact factor: 2.490

2.  Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.

Authors:  Ernest T Parker; Pete Lollar
Journal:  Biochemistry       Date:  2007-08-04       Impact factor: 3.162

3.  Partial correction of a severe molecular defect in hemophilia A, because of errors during expression of the factor VIII gene.

Authors:  M Young; H Inaba; L W Hoyer; M Higuchi; H H Kazazian; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

4.  Hemophilia A due to mutations that create new N-glycosylation sites.

Authors:  A M Aly; M Higuchi; C K Kasper; H H Kazazian; S E Antonarakis; L W Hoyer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families.

Authors:  P P Deutz-Terlouw; M Losekoot; R Olmer; W C Pieneman; S de Vries-v d Weerd; E Briët; E Bakker
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

6.  Detection of mutations in ectopic factor VIII transcripts from nine haemophilia A patients and the correlation with phenotype.

Authors:  S I Bidichandani; W G Lanyon; C R Shiach; G D Lowe; J M Connor
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

7.  Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants.

Authors:  D Nance; R A Campbell; J W Rowley; J M Downie; L B Jorde; W H Kahr; S A Mereby; N D Tolley; G A Zimmerman; A S Weyrich; M T Rondina
Journal:  J Thromb Haemost       Date:  2016-10-20       Impact factor: 5.824

8.  Characterization of the factor VIII defect in 147 patients with sporadic hemophilia A: family studies indicate a mutation type-dependent sex ratio of mutation frequencies.

Authors:  J Becker; R Schwaab; A Möller-Taube; U Schwaab; W Schmidt; H H Brackmann; T Grimm; K Olek; J Oldenburg
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

Review 9.  Haemophilia: strategies for carrier detection and prenatal diagnosis.

Authors:  I R Peake; D P Lillicrap; V Boulyjenkov; E Briet; V Chan; E K Ginter; E M Kraus; R Ljung; P M Mannucci; K Nicolaides
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

10.  Identification of FVIII gene mutations in patients with hemophilia A using new combinatorial sequencing by hybridization.

Authors:  M Chetta; A Drmanac; R Santacroce; E Grandone; S Surrey; P Fortina; M Margaglione
Journal:  Indian J Hum Genet       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.